Skip to content
10-Q

Quarterly Report

ESCALON MEDICAL CORP ESMC

0000862668-23-000008

← back to feed
Filed
Feb 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Feb 13, 2023 7.42M sh
Current Liabilities Q2 2023 · Dec 31, 2022 $2.96M
Current Liabilities Q2 2023 · Jun 30, 2022 $3M
Total Liabilities Q2 2023 · Dec 31, 2022 $3.49M
Total Liabilities Q2 2023 · Jun 30, 2022 $3.69M
Current Assets Q2 2023 · Dec 31, 2022 $3.81M
Current Assets Q2 2023 · Jun 30, 2022 $4.19M
Total Assets Q2 2023 · Dec 31, 2022 $4.64M
Total Assets Q2 2023 · Jun 30, 2022 $5.17M
Shares Diluted Q2 2023 · Dec 31, 2021 7.42M sh
Shares Diluted Q2 2023 · Dec 31, 2021 13.05M sh
Operating Cash Flow Q2 2023 · Dec 31, 2021 −$581.45K
Cash And Equivalents Q2 2023 · Dec 31, 2021 $1.07M
Cash And Equivalents Q2 2023 · Jun 30, 2021 $1.65M
Stockholders Equity Q2 2023 · Dec 31, 2021 $1.72M
Stockholders Equity Q2 2023 · Sep 30, 2021 $1.78M
Stockholders Equity Q2 2023 · Jun 30, 2021 $1.46M
Eps Diluted Q2 2023 · Dec 31, 2021 −$0.01
Eps Diluted Q2 2023 · Dec 31, 2021 $0.02
Eps Basic Q2 2023 · Dec 31, 2021 −$0.01
Eps Basic Q2 2023 · Dec 31, 2021 $0.03
Sga Expense Q2 2023 · Dec 31, 2021 $949.81K
Sga Expense Q2 2023 · Dec 31, 2021 $1.85M
Rd Expense Q2 2023 · Dec 31, 2021 $260.44K
Rd Expense Q2 2023 · Dec 31, 2021 $551.63K
Net Income Q2 2023 · Dec 31, 2021 −$53.15K
Net Income Q2 2023 · Dec 31, 2021 $264.07K
Net Income Q2 2023 · Sep 30, 2021 $317.22K
Operating Income Q2 2023 · Dec 31, 2021 −$49.05K
Operating Income Q2 2023 · Dec 31, 2021 −$233.54K
Cost Of Revenue Q2 2023 · Dec 31, 2021 $1.54M
Cost Of Revenue Q2 2023 · Dec 31, 2021 $3.2M